BK vs ERNA · P/E 17, rev $20.08B vs P/E 0.0, rev $582.0K
The Bank of New York Mellon Corporation (BK) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BK currently screens at market cap $94.14B and trailing P/E 17.0. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BK and ERNA stock pages for the full models.
Not investment advice.